Gilead Sciences to Present at Two Upcoming Investor Conferences
March 07 2011 - 4:30PM
Business Wire
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that the
company will be webcasting its corporate presentation at two
upcoming investor conferences: the ROTH Growth Stock Conference in
Dana Point, California and the Barclays Global Healthcare
Conference in Miami.
John F. Milligan, PhD, Gilead’s President and Chief Operating
Officer, will provide an overview of the company at the ROTH
conference on Monday, March 14 at 12:30 p.m. Pacific Daylight Time
(3:30 p.m. Eastern Daylight Time (EDT).
Kevin Young, Gilead’s Executive Vice President, Commercial
Operations, will provide an overview of the company at the Barclays
conference on Tuesday, March 15 at 9:00 a.m. EDT.
To access the live webcasts via the internet log on to
www.gilead.com. Please connect to the company’s website at least 15
minutes prior to each live presentation to ensure adequate time for
any software download that may be necessary to listen to the
webcast.
About Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers,
develops and commercializes innovative therapeutics in areas of
unmet medical need. The company’s mission is to advance the care of
patients suffering from life-threatening diseases worldwide.
Headquartered in Foster City, California, Gilead has operations in
North America, Europe and Asia Pacific.
For more information on Gilead Sciences, please
visit www.gilead.com or call the Gilead Public Affairs Department
at 1-800-GILEAD-5 (1-800-445-3235).
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From May 2024 to Jun 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Jun 2023 to Jun 2024